Cargando…

The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?

Mesenchymal stromal cells (MSCs) comprise a heterogeneous population of multipotent stromal cells that have gained attention for the treatment of irradiation-induced normal tissue toxicities due to their regenerative abilities. As the vast majority of studies focused on the effects of MSCs for photo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rühle, Alexander, Grosu, Anca-Ligia, Nicolay, Nils H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071947/
https://www.ncbi.nlm.nih.gov/pubmed/33912447
http://dx.doi.org/10.3389/fonc.2021.616831
_version_ 1783683816610594816
author Rühle, Alexander
Grosu, Anca-Ligia
Nicolay, Nils H.
author_facet Rühle, Alexander
Grosu, Anca-Ligia
Nicolay, Nils H.
author_sort Rühle, Alexander
collection PubMed
description Mesenchymal stromal cells (MSCs) comprise a heterogeneous population of multipotent stromal cells that have gained attention for the treatment of irradiation-induced normal tissue toxicities due to their regenerative abilities. As the vast majority of studies focused on the effects of MSCs for photon irradiation-induced toxicities, little is known about the regenerative abilities of MSCs for particle irradiation-induced tissue damage or the effects of particle irradiation on the stem cell characteristics of MSCs themselves. MSC-based therapies may help treat particle irradiation-related tissue lesions in the context of cancer radiotherapy. As the number of clinical proton therapy centers is increasing, there is a need to decidedly investigate MSC-based treatments for particle irradiation-induced sequelae. Furthermore, therapies with MSCs or MSC-derived exosomes may also become a useful tool for manned space exploration or after radiation accidents and nuclear terrorism. However, such treatments require an in-depth knowledge about the effects of particle radiation on MSCs and the effects of MSCs on particle radiation-injured tissues. Here, the existing body of evidence regarding the particle radiobiology of MSCs as well as regarding MSC-based treatments for some typical particle irradiation-induced toxicities is presented and critically discussed.
format Online
Article
Text
id pubmed-8071947
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80719472021-04-27 The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond? Rühle, Alexander Grosu, Anca-Ligia Nicolay, Nils H. Front Oncol Oncology Mesenchymal stromal cells (MSCs) comprise a heterogeneous population of multipotent stromal cells that have gained attention for the treatment of irradiation-induced normal tissue toxicities due to their regenerative abilities. As the vast majority of studies focused on the effects of MSCs for photon irradiation-induced toxicities, little is known about the regenerative abilities of MSCs for particle irradiation-induced tissue damage or the effects of particle irradiation on the stem cell characteristics of MSCs themselves. MSC-based therapies may help treat particle irradiation-related tissue lesions in the context of cancer radiotherapy. As the number of clinical proton therapy centers is increasing, there is a need to decidedly investigate MSC-based treatments for particle irradiation-induced sequelae. Furthermore, therapies with MSCs or MSC-derived exosomes may also become a useful tool for manned space exploration or after radiation accidents and nuclear terrorism. However, such treatments require an in-depth knowledge about the effects of particle radiation on MSCs and the effects of MSCs on particle radiation-injured tissues. Here, the existing body of evidence regarding the particle radiobiology of MSCs as well as regarding MSC-based treatments for some typical particle irradiation-induced toxicities is presented and critically discussed. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8071947/ /pubmed/33912447 http://dx.doi.org/10.3389/fonc.2021.616831 Text en Copyright © 2021 Rühle, Grosu and Nicolay https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Rühle, Alexander
Grosu, Anca-Ligia
Nicolay, Nils H.
The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
title The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
title_full The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
title_fullStr The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
title_full_unstemmed The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
title_short The Particle Radiobiology of Multipotent Mesenchymal Stromal Cells: A Key to Mitigating Radiation-Induced Tissue Toxicities in Cancer Treatment and Beyond?
title_sort particle radiobiology of multipotent mesenchymal stromal cells: a key to mitigating radiation-induced tissue toxicities in cancer treatment and beyond?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071947/
https://www.ncbi.nlm.nih.gov/pubmed/33912447
http://dx.doi.org/10.3389/fonc.2021.616831
work_keys_str_mv AT ruhlealexander theparticleradiobiologyofmultipotentmesenchymalstromalcellsakeytomitigatingradiationinducedtissuetoxicitiesincancertreatmentandbeyond
AT grosuancaligia theparticleradiobiologyofmultipotentmesenchymalstromalcellsakeytomitigatingradiationinducedtissuetoxicitiesincancertreatmentandbeyond
AT nicolaynilsh theparticleradiobiologyofmultipotentmesenchymalstromalcellsakeytomitigatingradiationinducedtissuetoxicitiesincancertreatmentandbeyond
AT ruhlealexander particleradiobiologyofmultipotentmesenchymalstromalcellsakeytomitigatingradiationinducedtissuetoxicitiesincancertreatmentandbeyond
AT grosuancaligia particleradiobiologyofmultipotentmesenchymalstromalcellsakeytomitigatingradiationinducedtissuetoxicitiesincancertreatmentandbeyond
AT nicolaynilsh particleradiobiologyofmultipotentmesenchymalstromalcellsakeytomitigatingradiationinducedtissuetoxicitiesincancertreatmentandbeyond